Katie Southward

Value of Mismatch Repair, <i>KRAS</i> , and <i>BRAF</i> Mutations in Predicting Recurrence and Benefits From Chemotherapy in Colorectal Cancer

Gordon Hutchins, Katie Southward, Kelly Handley et al. · Journal of Clinical Oncology · 2011 · 675 citations · Full text

<scp>HER2</scp> overexpression and amplification as a potential therapeutic target in colorectal cancer: analysis of 3256 patients enrolled in the <scp>QUASAR</scp>, <scp>FOCUS</scp> and <scp>PICCOLO</scp> colorectal cancer trials

Susan D. Richman, Katie Southward, Philip Chambers et al. · The Journal of Pathology · 2015 · 231 citations · Full text

Cross-laboratory validation of the OncoScan® FFPE Assay, a multiplex tool for whole genome tumour profiling

Joseph Foster, Assa Oumie, Fiona S. Togneri et al. · BMC Medical Genomics · 2015 · 90 citations · Full text

Intratumoral stromal morphometry predicts disease recurrence but not response to 5‐fluorouracil—results from the <scp>QUASAR</scp> trial of colorectal cancer

Gordon G.A. Hutchins, Darren Treanor, Alexander Wright et al. · Histopathology · 2017 · 26 citations · Full text

Preoperative chemoradiation with capecitabine, irinotecan and cetuximab in rectal cancer: significance of pre-treatment and post-resection RAS mutations

Simon Gollins, David Sebag‐Montefiore, Arthur Sun Myint et al. · British Journal of Cancer · 2017 · 24 citations · Full text